Navigation Links
Letter Challenges Biovail CEO to a Debate
Date:6/16/2008

TORONTO, June 16 /PRNewswire/ -- The Concerned Shareholders of Biovail Corporation (NYSE: BVF)(TSX: BVF) today sent the following letter to William Wells, CEO of Biovail Corporation:

June 16, 2008

William Wells

Chief Executive Officer

Biovail Corporation

7150 Mississauga Road

Mississauga, Ontario l5N 8M5

Dear Mr. Wells:

I am writing to suggest a live, face-to-face debate between the two of us either Wednesday or Thursday of this week.

Biovail shareholders have an important decision to make in this upcoming proxy contest. It is a choice between you and your current board and the board slate proposed by the Concerned Shareholders and it revolves around two central issues:

-- which board slate has the stronger qualifications to rebuild value for

Biovail shareholders, and

-- which board slate has the better strategic plan to achieve that goal?

I propose that we allow shareholders to hear from the company's current CEO and the proposed CEO (me) and decide for themselves.

Howard Green of ROBTV has agreed to moderate the debate. If for some reason, he is unacceptable to you, we would agree to have it moderated by a respected financial journalist who is mutually acceptable to both of us. I am also willing to have it held at any location of your choosing should that be necessary. It would also be broadcast live over the Internet, unedited and in real time.

The Concerned Shareholders will pay for all production and related costs. The debate would be broadcast real-time as streaming video on our web site, and we would provide streaming video for you to broadcast simultaneously at http://www.biovail.com. Both parties would be free to provide archived re-broadcast of the debate, with the understanding that neither party would edit the debate video for archived rebroadcast.

I propose that the debate last for 60 minutes, and that we adopt a format similar to one used in many political debates, but slightly modified due to the technical nature of the pharmaceutical Industry: the journalist/moderator would prepare three questions, to be asked of both of us and each of us would ask three questions of the other. We would be given three minutes maximum to answer each question; the other person would have three minutes to respond and then each party would have one minute for rebuttal to the other party's responses. We would alternate "first answers" so that both parties would have equal opportunity. Each party would also be given 3 minutes for a final closing statement. We could use coin flips to determine which party would be the "first-answerer" of the first question, and to determine which party has the right to decide whether to be the first or second person to deliver the closing statement.

I believe having this information is critical to our shareholders deciding which slate they should vote for at the upcoming Annual General Meeting on June 25, 2008.

As mentioned previously, given the limited time available, I propose that the debate be conducted on June 18 or June 19. I am willing to modify my schedule to meet whatever time restrictions you might face.

I hope that you will accept this invitation to debate. I believe the shareholders of Biovail deserve no less than to hear directly from the two of us -- unfiltered by lawyers, consultants, and spin doctors, to help them decide who is better qualified to lead the company forward after the June 25 AGM. Given the time required to make arrangements, I request that you respond to this invitation no later than 12:00 noon EDT on Tuesday, June 17.

Sincerely,

Bruce Brydon


'/>"/>
SOURCE Bruce Brydon
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Alseres Pharmaceuticals, Inc.s Chairman, Peter Savas, Reviews Companys Progress in its Annual Letter to Stockholders
2. Renhuang Pharmaceuticals, Inc. Holds Trade Show for Tianma Pills; Signs Letters of Intent
3. Immucor Responding to FDA Warning Letter
4. AMDL Signs Letter of Intent to Purchase a China Based Pharmaceutical Distribution Company
5. Osteotech Announces the Unexpected Passing of Audit Committee Member Leads to Receipt of Nasdaq Deficiency Letter
6. OPEN LETTER: Medical Journal Calls Upon Barack Obama to Set the Record Straight on AIDS Virus
7. Digirad Corporation and University of Chicago Medical Center Sign Letter of Agreement
8. QMed, Inc. Receives NASDAQ Delisting Letter
9. Internet Auction Site LabX Acquires Lab Manager Magazine(R) Print and Digital Publications, E-Newsletters, Website and Conference
10. Letter to Z Trim Shareholders
11. Breckenridge Pharmaceutical Signs Letter of Intent for Long Term Agreement With Orit Laboratories (West Caldwell, NJ)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , ... February 08, 2016 , ... ... enrichment program serving the greater Venice, FL area, has initiated a fundraiser for ... a car accident just four days after Christmas. To support this beautiful child ...
(Date:2/8/2016)... ... February 08, 2016 , ... Remember the old saying ... , According to Perry A~, author of “Calcium Bentonite Clay” the health benefits of ... in balancing and detoxifying the body. , A former motivational speaker, Perry A~ has ...
(Date:2/8/2016)... ... ... Discover the Rocky Mountain region’s longest running and impressive garden and home show where ... see the most incredible gardens and home improvement experts that attend this amazing show. ... - 700 14th St. Denver CO, is an exciting event that Performance Mobility has ...
(Date:2/8/2016)... KS (PRWEB) , ... February 08, 2016 , ... TopConsumerReviews.com ... leader in Mole removal products. , Moles are derived from a cluster of melanin ... in all the wrong places and create a lifetime of embarrassment. Historically, mole ...
(Date:2/8/2016)... ... February 08, 2016 , ... The schedule is now online ... AutismOne 2016 Conference, which is being held May 25-29 at the Loews Chicago O’Hare ... helpful interventions and causes of chronic illness in children. , Very recent articles have ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... Feb. 8, 2016 Velano Vascular, a medical ... hospitalized patients and their practitioners, announced today that the ... Velano will use the proceeds from this financing, an ... in January 2015, to support the development and commercialization ... pediatric populations. Philadelphia , ...
(Date:2/8/2016)... CARLSBAD, Calif. , Feb. 8, 2016  HemaFlo Therapeutics, ... Office (USPTO) has issued US Patent Number 9,119,880 covering the ... Dale Peterson , PhD, HemaFlo,s founder, said, "We ... technology." --> Dale Peterson , PhD, HemaFlo,s ... such a powerful technology." --> Dale ...
(Date:2/8/2016)... , Feb. 8, 2016  Astellas Pharma Inc. President and ... promotion of James Robinson as president, Americas Operations, ... in North and South America , effective ... US, representing the commercial organization in the United ... Masao Yoshida , who is retiring in ...
Breaking Medicine Technology: